 MINNEAPOLIS, April 27, 2021 GLOBE NEWSWIRE -- Predictive Oncology NASDAQ: POAI, a knowledge-driven company focused on applying artificial intelligence AI to personalized medicine and drug discovery, is excited to announce today their newest Board Member Dr. Christina Jenkins. 